The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Tocilizumab and COVID-19: Timing of Administration and Efficacy
|
|---|---|
| Published in |
Frontiers in Pharmacology, February 2022
|
| DOI | 10.3389/fphar.2022.825749 |
| Pubmed ID | |
| Authors |
Emna Abidi, Wasim S. El Nekidy, Eman Alefishat, Nadeem Rahman, Georg A. Petroianu, Rania El-Lababidi, Jihad Mallat |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 56 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 7 | 13% |
| Student > Bachelor | 7 | 13% |
| Student > Postgraduate | 5 | 9% |
| Other | 3 | 5% |
| Professor > Associate Professor | 3 | 5% |
| Other | 6 | 11% |
| Unknown | 25 | 45% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 10 | 18% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 9% |
| Chemistry | 3 | 5% |
| Agricultural and Biological Sciences | 3 | 5% |
| Biochemistry, Genetics and Molecular Biology | 2 | 4% |
| Other | 7 | 13% |
| Unknown | 26 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 February 2022.
All research outputs
#15,575,964
of 23,151,189 outputs
Outputs from Frontiers in Pharmacology
#6,633
of 16,540 outputs
Outputs of similar age
#250,484
of 438,196 outputs
Outputs of similar age from Frontiers in Pharmacology
#481
of 1,304 outputs
Altmetric has tracked 23,151,189 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,540 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,196 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,304 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.